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Myeloperoxidase anti-neutrophil cytoplasmic autoantibody (MPO-ANCA) is a well known marker
for small vessel vasculitis. Recent reports have demonstrated that interstitial pneumonia (IP)
may rarely be associated with serum MPO-ANCA. Yet, little is known about the histological
features.
We reviewed surgical lung biopsy from nine patients with IP of uncertain etiology with serum
MPO-ANCA.
There was a male predominance (6:3) with a median age of 62.1. Histologically, eight
patients presented with a usual interstitial pneumonia (UIP) pattern of pulmonary fibrosis,
frequently accompanied by areas of nonspecific interstitial pneumonia (NSIP) pattern. One
patient showed diffuse alveolar damage (DAD), and two patients showed mixture of UIP and
DAD reflecting acute exacerbation of UIP. Microscopic honeycomb cysts were common, but
fibroblastic foci were inconspicuous. The most frequent additional findings were small airway
disease (9/9), and lymphoid follicles (7/9). Neither capillaritis nor vasculitis was seen in any of
our cases. Three patients had microscopic hematuria, but none progressed to microscopic
polyangiitis during the follow up. Mortality rate was 44% (median follow up 39.1 months).
IP associated with MPO-ANCA showed characteristic histology dominated by UIP pattern.
Vasculitis was not identified in our cohort, but small airways disease and lymphoid folliclesof Surgical Pathology, Toyama University Hospital, 2630 Sugitani, Toyama 930-0194, Japan. Tel.: þ81
oyama.ac.jp (J. Fukuoka).
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1766 T. Tanaka et al.were present in most cases. IP associated with MPO-ANCA may be a histologically distinctive
disease from idiopathic pulmonary fibrosis. Mortality was relatively high and life threatening
acute exacerbation may occur.
ª 2012 Elsevier Ltd. All rights reserved.Introduction
Serum myeloperoxidase anti-neutrophil cytoplasmic auto-
antibody (MPO-ANCA) is not specific for any single disease
and can be found in a variety of vasculitides, most
commonly microscopic polyangiitis (MPA). However the
precise biological mechanisms remain unknown.1
Recent reports have shown that some patients with inter-
stitial pneumonia (IP) may have positive serum MPO-ANCA
without developing known vasculitis. The number of publica-
tions on this topic is limited and the histological features of IP
associatedwith serumMPO-ANCAhavenotbeenwell-defined.2
Based on existing reports, themajority of affected patients do
not progress to MPA over the course of their disease.3
Newly published guidelines on the diagnosis and
management of idiopathic pulmonary fibrosis (IPF) empha-
size the importance of separating IPF from IP associated
with specific systemic conditions such as those related to
the collagen vascular diseases. If IP associated with MPO-
ANCA is a distinctive form of pulmonary fibrosis, it should
be separated from IPF. In that case, alternative therapy
may be considered, especially since these individuals are
not likely to qualify for clinical trials targeting IPF.4
In the present study, we describe the histopathologic
findings and survival in a group of patients with IP associ-
ated with elevated serum MPO-ANCA.Materials and methods
Thepulmonarypathology consultationfiles of theDepartment
of Surgical pathology, Toyama University Hospital, from 2008
to 2011, were reviewed in order to identify cases that showed
interstitial pneumonia accompanied by elevated levels of
serum MPO-ANCA. Clinical data, including age, gender,
smoking history, symptoms, existence of MPA and follow up
datawere obtained frompatientmedical records. Laboratory
and pulmonary function data at the initial presentation were
also recorded. All patientswere evaluated for the presence of
autoimmune antibodies including anti-nuclear antibody
(ANA),MPO-ANCA,andproteinase-3 (PR3)-ANCA.According to
the Japanese guideline for idiopathic interstitial pneumo-
nias,5 basically all interstitial pneumonia cases are recom-
mended to examine serum ANA, MPO-ANCA, PR3-ANCA and
other autoimmune antibody as a routine screening test to
exclude the collagen vascular disease from idiopathic inter-
stitial pneumonias. In the guideline, the serum MPO-ANCA
level of >20 EU is suggested to be positive.
Radiological review: high-resolution computed tomog-
raphy (HRCT) scans of the chest at the time of biopsy were
available for all patients. The HRCT scans were reviewed in
a blinded fashion by a chest radiologist (R.E.) experienced
in the interpretation of diffuse lung disease and wereclassified using the radiologic patterns described in the
ATS/ERS International Consensus Classification 2002 of the
Idiopathic Interstitial Pneumonias (IIPs).6
Histologic review: all lungbiopsy specimenswere reviewed
independently by two pathologists (J.F., T.T.). Each biopsy
was classified using the histopathologic patterns described in
theATS/ERS InternationalConsensusClassification2002of the
IIPs. In cases where there was disagreement, a consensus was
established through further review. The following histologic
features were semi-quantitatively graded: marked dense
fibrosis (MF: , absent; þ weak; þþ, strong), patchy fibrosis
(PF: , absent; þ weak; þþ, strong), honeycomb change
(HC:, absent;þ,weak;þþ, strong), fibroblastic foci (FF:,
absent; þ, weak; þþ, strong), capillaritis (CA: , absent; þ
weak; þþ, strong), vasculitis (VA: , absent; þ weak; þþ,
strong), lymphoid follicle with germinal center (LY: ,
absent; þ, weak; þþ,strong), small airway disease (SAD: ,
absent; þ, weak; þþ, strong). When small airway diseases
were observed, they were divided into three subtypes,
cellular, cellular and fibrotic, and fibrotic, depending on the
predominance of inflammation and fibrosis. Follicular bron-
chiolitis was included in cellular bronchiolitis.
If other relevant histological findings (e.g. granuloma)
were present, they were also documented. The evaluation
for capillaritis and vasculitis was performed using slides
stained with H&E and elastica van Gieson (EVG) stainings.
To understand the clinical outcome, a Kaplan Meier curve
was plotted, and a median survival time was pointed out.
The study protocol was approved by the Institutional
Review Board of Toyama University Hospital.Results
Clinical findings
Among total of 272 cases sent from the three institutes for
consultation to the pathology archive of interstitial pneu-
monia at Toyama University Hospital, 224 patients were
available for MPO-ANCA levels at the time of biopsy. Out of
those 224 patients, we identified nine patients showing
higher levels of MPO-ANCA. PR3-ANCA levels were also
tested for majority of patients at the time of biopsy, which
showed 4 out of 219 patients were positive. Only one
patient, patient 2, showed positive for both MPO and PR3-
ANCA. Data of other autoimmune antibodies were also
available at the time of biopsy, which showed positive for
RF, 50/222; ANA, 41/227; SS-A, 20/216; Jo-1, 10/231; RNP,
6/151; Scl-70, 2/215 and SS-B, 1/194.The mean age of
elevated serum MPO-ANCA patients was 62.1 years with
a male predominance (M:FZ 6:3). Three patients demon-
strated microscopic hematuria, while two patients who
were detected on a health check-up had no symptoms. A
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patients had restrictive impairment. Follow up ranged from
19 to 72 months (mean 39.1). Four patients died during the
follow up period; two of whom had acute exacerbation.
(Table 1) Median survival time was 46 months (Fig. 3). With
available follow up, none of the patients in our study pro-
gressed to MPA. Also, the three patients who showed
microscopic hematuria did not progress to MPA during the
period of follow up. No patients had renal biopsy because
the renal symptoms, if any, were subtle. The laboratory
findings including the levels of serum MPO-ANCA were
shown in Table 2.
Radiological findings
HRCT scans were available for all patients and radiographic
patterns of each case are shown in Table 2. The most
common findings were bilateral reticulo-nodular shadows
superimposed on ground glass opacities. CT findings were
classified as presenting a UIP pattern in six cases, showing
honeycomb change with reticular abnormality (Fig. 2A).
Patient 3 showed an NSIP pattern with predominant ground
glass opacity without honeycomb change. Patient 1 showed
organizing pneumonia (OP) with patchy distribution of
consolidation. Patient 8 showed a mixture of reticulo-
nodular shadows and diffuse ground glass findings consis-
tent with acute exacerbation of background interstitial
fibrosis (Fig. 2B). Patient 9 showed ground glass opacity
with traction bronchioloectasis, suspicious of DAD.
Histological findings
Biopsies for each patient were obtained from one to three
sites of the lung. Histological features are summarized in
Table 3. The histological investigation revealed a UIP
pattern in eight out of nine patients. All UIP cases showed
marked dense fibrosis in mostly peripheral areas of
secondary lobules. Seven out of eight UIP cases showed
honeycomb changes in which the sizes of the cysts were up
to 10 mm in diameter (Fig. 1AeC). Fibroblastic foci were
inconspicuous in six out of eight UIP cases, while two casesTable 1 Patients demographics of Interstitial Pneumonia assoc
Age Gender Symptom
Patient 1 59 F Fever, arthralgia
Patient 2 71 M DOE, bloody sputum,
recurrent fever
Patient 3 69 M DOE, microscopic
hematuria
Patient 4 58 F DOE, microscopic
hematuria
Patient 5 62 F Nonea
Patient 6 59 M Dry cough
Patient 7 54 M Pancreatitis
Patient 8 58 M Microscopic hematuria
Patient 9 69 M Nonea
MPA, microscopic polyangiitis; AE, acute exacerbation of chronic dis
sporine A; NA, data not available.
a These patients’ diseases were found by health check.showed scattered foci. Most UIP patients had NSIP-like
areas as a minor component of their disease, with
uniform distribution of fibrosis. Two patients exhibited UIP
with superimposed DAD (Fig. 1D). The two patients were
suspected histologically of having acute exacerbation of
chronic fibrosing interstitial pneumonia. A CT scan of the
same case confirmed the DAD radiologically, and a clin-
icaleradiologicalepathological (CRP) consensus diagnosis
of acute exacerbation of UIP was established. Another
patient, case 1, showed DAD in the organizing phase.
Anadditional frequent and characteristic finding commonly
seen in IP associated with MPO-ANCA is small airway disease.
Three of the nine patients showed cellular bronchiolitis
exhibiting lymphoplasmacytic infiltration around the airway
with littlefibrosis (Fig. 1E) inwhich twoaccompanied lymphoid
follicles with germinal center, showing features of follicular
bronchiolitis. Five of the nine patients showed combined
cellular and fibrotic bronchiolitis. One patient demonstrated
purely fibrotic bronchiolitis. One patient (Patient 3) also
showedmild constrictive bronchiolar fibrosis on top of cellular
bronchiolitis in some membranous bronchioles.
Another characteristic finding in the current study was
the presence of lymphoid follicles with a germinal center
(Fig. 1A, B, E). Seven of the nine patients showed lymphoid
follicles with a germinal center. No patient showed
evidence of capillaritis or vasculitis, however, two patients
showed mild lymphocytic infiltration inside the vessel walls
(lymphocytic vasculopathy) (Fig. 1F). Case 2 showed
a single non-necrotizing, poorly formed granuloma, which
was considered as an incidental finding.Discussion
The present study has shown that interstitial pneumonia of
unknown cause with elevated serum MPO-ANCA exhibits
characteristic histopathology dominated by advanced
fibrous remodeling of UIP pattern. Capillaritis and/or
vasculitis were not identified but small airway disease and
lymphoid follicles were commonly seen in our study. The
prognosis seems to be poor. Frequency of acute exacerba-
tion is not clear but may be as high as IPF.4iated with MPO-ANCA.
MPA AE Treatment Follow up (Mo) Status
No  PSL 48 Dead
No  PSLþ CyA 25 Alive
No  PSLþ CyA 72 Alive
No þ PSLþ CyA 35 Dead
No  Untreated 21 Alive
No þ PSLþ CyA 33 Dead
No  PSLþ CyA 19 Alive
No þ PSLþ CyA 53 Alive
NA  PSLþ CyA 46 Dead
ease; DOE, dyspnea on exertion; PSL, prednisolone; CyA, cyclo-
Figure 1 Histopathological features of Interstitial Pneumonia Associated with MPO-ANCA. (A) Lower power view (1) of patient
2. Large cystic spaces possibly honeycombing can be seen. Basic lung architecture is totally distorted (H&E stain). (B) Lower power
view (1) of Patient 8 shows patchy dense fibrosis accentuated in the peripheral zones of the lobules corresponding to UIP pattern
(H&E stain). (C) Higher power view (4) of the same case shows dense collagenous fibrosis with architectural destruction along with
cystic spaces possibly microscopic honeycombing (H&E stain). (D) Another lobe of the patients 8 showed hyaline membranes
indicating DAD (H&E staining, 10). (E) Low power view (1) of another lobe of the patients 2 showed small airway disease (H&E
stain). (F) High power view of same lobe revealed vasculopathy. Note preservation of elastic lamina in the vascular wall (EVG stain,
20).
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pleuropulmonary manifestations. For most of the CVD,
except rheumatoid arthritis, NSIP histology is a common
manifestation.7,8 In the present study, eight out of nine
patients had UIP pattern as a major histology. Our data, the
predominance of UIP in IP associated with MPO-ANCA, was
identical to previous reports.3 UIP histology may be a char-
acteristic presentation of IP associated with MPO-ANCA.
However, the vast majority of our cases showed a signifi-
cant mixture of NSIP patterns in the same biopsy. Similar toIP associated with CVD, the atypical UIP histology may be
a histological features of IP associated with MPO-ANCA.
Recently interstitial pneumonia with highly suspected
relation to collagen vascular disease but not fulfilling the
criteria of defined collagen vascular disease is categorized
under three different names: undifferentiated connective
tissue disease (UCTD),9,10 lung dominant connective tissue
disease,11 and autoimmune-featured interstitial lung
disease.12 Among them, serum ANCA was included in the
criteria of autoimmune-featured interstitial lung disease
Figure 2 CT findings of Interstitial Pneumonia Associated with MPO-ANCA Patient 2 (A) showed relatively large sized cyst and
honeycomb change at subpleural predominance in the lung base. Patient 8 (B) demonstrated reticulo-nodular shadows as
a background finding superimposed of diffuse ground glass opacity corresponding to acute exacerbation.
Figure 3 Kaplan Meier curve of patients with interstitial
pneumonia associated with MPO-ANCA. Eight out of nine
patients had follow up data. A Kaplan Meier curve was plotted.
All four cases experiencing death of the disease were due to
acute exacerbation of chronic interstitial pneumonia of usual
interstitial pneumonia. Median survival time of all patients was
46 months.
Interstitial pneumonia associated with MPO-ANCA 1769without clear evidence as background. Fischer et al.
proposed four histological criteria for lung dominant
connective tissue disease; most cases of the present study
suit at least one of the criteria, lymphoid follicle withTable 2 Smoking status, laboratory findings and CT features.
Smoking Pack year MPO-ANCA [EU] Autoantib
Patient 1 Never 0 24 Negative
Patient 2 Ex 45 35.2 Negative
Patient 3 Ex 50 90 ANA(640
Patient 4 Never 0 Positivea Negative
Patient 5 Never 0 205.0 Negative
Patient 6 Ex 15 31 ANA(320
Patient 7 Ex 42 34.9 ANA(640
Patient 8 Current 57 39.1 Negative
Patient 9 Ex 90 Positive ANA(160
Ex, ex-smoker; NA, data not available.
a Exact level of MPO-ANCA was not given.germinal center.11 Also, all patients in the present study
showed small airway disease in which cellular and follicular
bronchiolitis were frequent histological patterns. Small
airway disease is also common in IP associated with
CVD.11,13 Considering these overlaps with CVD, interstitial
pneumonia associated with serum MPO-ANCA may fit better
within the context of connective tissue disease with related
interstitial lung disease than with IPF that has an incidental
serum elevation of MPO-ANCA.14
Our study indicates that the histopathology of IP asso-
ciated with MPO-ANCA is discernibly different from that of
IPF and suggests that these cases may be regarded and
treated more like a systemic rheumatic disease manifesting
in the lung.
In the report of Homma et al., 13 of the 31 patients died
of deteriorations related to the disease.3 The occurrence of
DAD in a subset of our study patients is important and
suggests that patients with IP associated with MPO-ANCA
may be at relatively high risk for acute exacerbation.
This time, we focused on interstitial pneumonia associ-
ated with MPO-ANCA. Overlap and differences of clinico-
pathological features from other auto-antibodies are not
known. Further studies to investigate exact relationship
between types of autoantibody and clinicopathological
data are needed.
A limitation of the current study is the small number of
patients and the retrospective nature of our case identifi-
cation. Further studies will be required with a larger
number of patients to confirm our observations.ody KL-6 [U/ml] %VC %FEV1.0 %Dlco CT pattern
187 68.1 NA 76.1 OP
588 69.9 83.0 69.7 UIP
) 2120 74.3 NA 50.0 NSIP
2200 56.0 74.2 32.3 UIP
339 104.7 105.9 80.4 UIP
) 1743 102.8 94.0 91.8 UIP
) 508 74.2 74.0 NA UIP
714 52.9 51.5 26.2 UIP
) NA 98.1 106.6 81.5 DAD
Table 3 Histological findings of interstitial pneumonia associated with MPO-ANCA.
Pathologic
pattern
MF PF HC FF Capillaritis/
vasculitis
Vasculopathy Lymphoid
follicle
Small airway
disease
(Subtype)
Other
findings
Patient 1 DAD        þ F
Patient 2 UIP þ þþ þþ   þ þþ þþ C Granuloma
Patient 3 UIP þþ þ þ   þ þþ þ C (FB)þ F Constrictive
change
Patient 4 UIP þ þþ þ/ þþ   þ þ Cþ F
Patient 5 UIP þ þ þ    þþ þþ C (FB)þ F
Patient 6 UIP þþ þ þþ    þþ þþ C
Patient 7 UIP þþ þ þþ    þ þ C
Patient 8 UIPþ DAD þþ þ     þ þ Cþ F
Patient 9 UIPþ DAD þ þ  þ    þ Cþ F
MF, marked dense fibrosis; PF, patchy fibrosis; HC, microscopic honeycomb cyst; FF, fibroblastic focus; SAD, small airway disease; C,
cellular bronchiolitis; Cþ F, cellular and fibrotic bronchiolitis; F, fibrotic bronchiolitis; C (FB), follicular bronchiolitis.
1770 T. Tanaka et al.Conclusions
Interstitial pneumonia associated with MPO-ANCA has
characteristic histopathology dominated by usual intersti-
tial pneumonia pattern. Bronchiolitis and lymphoid follicles
were common as in connective tissue disease associated
with interstitial lung disease. Interstitial pneumonia asso-
ciated with MPO-ANCA may be a distinctive disease from
idiopathic pulmonary fibrosis. The prognosis seems to be
poor, and lethal acute exacerbation may occur.
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